^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

CK-102

i
Other names: CK-102, CEP–9722
Associations
News
Trials
Company:
Fortress, Teva
Drug class:
PARP1 inhibitor, PARP2 inhibitor
Associations
News
Trials